Follow this link:
Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19

Read more from the original source:
Gracell Biotechnologies to Participate in Upcoming Virtual Conferences in June

Read more from the original source:
Travere Therapeutics Provides Regulatory Update on Sparsentan Development Program for Focal Segmental Glomerulosclerosis

See the original post:
Chinook Therapeutics to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 58th ERA-EDTA Congress

Read the rest here:
Codexis to Participate in Upcoming Virtual Healthcare Conferences

More here:
Zosano Appoints Industry Veteran, Kathy McGee, to its Board of Directors

Visit link:
Kinnate Biopharma Inc. to Participate at the Goldman Sachs 42nd Annual Global Healthcare Conference

Originally posted here:
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

See the article here:
Prometheus Biosciences to Present at 2021 Jefferies Virtual Healthcare Conference

View post:
ObsEva Announces Proposed Changes to the Composition of its Board of Directors

See original here:
Adagene to Present at Upcoming Investor Conferences

Originally posted here:
Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences

See original here:
T2 Biosystems Reminds Stockholders to Vote at the Upcoming Annual Meeting

See the article here:
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired...

Read more from the original source:
Osmotica Pharmaceuticals plc to Present at Jefferies Virtual Healthcare Conference 2021

Original post:
TFF Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

Read the original:
Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing

Continued here:
Eurobio Scientific offers a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations of...

Continue reading here:
Bone Therapeutics Provides First Quarter 2021 Business Update

More:
Adocia Expands Clinical Development to Obesity with Patent Applications on Short-Acting Multihormonal Combinations Administered by Pumps